Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings

2 Nov 2011

Abstract excerpt

AIMS: Pharmacogenetic (PGx) tests are intended to improve therapeutic outcomes through predicting a patient's likelihood to respond to or experience an adverse effect from a specific treatment. In addition, PGx testing may also generate ancillary, or incidental, disease information unrelated to the purpose for which the test was ordered. To assess public attitudes toward PGx testing, ancillary disease risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics in Clinical Research
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22047505
DOI: 10.1089/gtmb.2011.0118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Public Perspectives About Pharmacogenetic Testing and Managing Ancillary FindingsPMID 22047505Read ↗

Pharmacogenetic testing: not as simple as it seems.Semantic proximity Read ↗

Delivering pharmacogenetic testing in a primary care settingSemantic proximity Read ↗

Collaborative Counseling Considerations for Pharmacogenomic TestsSemantic proximity Read ↗

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testingSemantic proximity Read ↗

Personalized genomic results: analysis of informational needs.Semantic proximity Read ↗

Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey studySemantic proximity Read ↗

Ancillary risk information and pharmacogenetic tests: social and policy implications.Semantic proximity Read ↗

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.Semantic proximity Read ↗

Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underservedSemantic proximity Read ↗

Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service.Semantic proximity Read ↗

Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.Semantic proximity Read ↗

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.